Parallel Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Parallel Advisors’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$36.5K	Buy	182 +169	+1,300%	+$35K	﹤0.01%	2180
2025 Q4	$2.69K	Hold	13	–	–	﹤0.01%	3055
2025 Q3	$2.33K	Hold	13	–	–	﹤0.01%	3009
2025 Q2	$2.1K	Hold	13	–	–	﹤0.01%	3034
2025 Q1	$2.21K	Hold	13	–	–	﹤0.01%	2950
2024 Q4	$2.16K	Hold	13	–	–	﹤0.01%	2944
2024 Q3	$2.23K	Hold	13	–	–	﹤0.01%	2861
2024 Q2	$2K	Sell	13 -8	-38%	-$1.2K	﹤0.01%	2811
2024 Q1	$3.23K	Sell	21 -15	-42%	-$2.29K	﹤0.01%	2662
2023 Q4	$5.69K	Hold	36	–	–	﹤0.01%	2484
2023 Q3	$5.27K	Buy	+36	New	+$5.49K	﹤0.01%	2486
2022 Q3	–	Sell	-48	Closed	-$7K	–	3249
2022 Q2	$7K	Buy	+48	New	+$6.62K	﹤0.01%	2127
2019 Q3	–	Sell	-20	Closed	-$3K	–	2416
2019 Q2	$3K	Hold	20	–	–	﹤0.01%	1976
2019 Q1	$3K	Buy	+20	New	+$2.88K	﹤0.01%	1964

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Parallel Advisors's FBT Position: Q1 2026 in Review

Parallel Advisors increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 1,300% in Q1 2026, buying an estimated $35K and bringing the position to 182 shares worth $36.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2180.

Parallel Advisors first reported a position in FBT in Q1 2019 and has held it in 14 quarters since. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

Parallel Advisors held 182 shares of First Trust NYSE Arca Biotechnology Index Fund worth $36.5K as of Q1 2026.
Parallel Advisors bought 169 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $35K.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #2180 holding.
Parallel Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2019 and has held it in 14 quarters since.
307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.